i-Base home
Search Menu
  • Home
  • HTB
  • 2004
  • April
  • 03

HTB

3 April 2004

Contents

Editorial

  • Volume 5 number 3 April 2004

Treatment alerts

  • Risk factors for severe, life-threatening and fatal hepatotoxicity with nevirapine

Conference reports

  • 11th Conference on Retroviruses and Opportunistic Infections (CROI)
  • Drug levels can persist for more than two weeks after stopping efavirenz
  • Race affects absorption and clearance of efavirenz
  • Triple PI interactions: atazanavir increases saquinavir levels in ritonavir-boosted once-daily combination
  • Triple PI interactions: fosamprenavir and Kaletra interaction is difficult to overcome
  • Ribavirin (RBV) does not alter intracellular levels of AZT, 3TC or d4T
  • COLATE study shows no clinical benefit from continuing 3TC to maintain M184V mutation
  • Studies of new pipeline drugs
  • Little benefit seen for treatment during acute infection
  • Summary of resistance studies at Retrovirus
  • Update on peripheral neuropathy in HIV-infection
  • Smoking marijuana provides analgesic effect on HIV neuropathy
  • Two D:A:D updates: cardiovascular risk from HAART, and predictors of hypertension and changes in blood pressure
  • Low-dose rHGH maintains reductions in abdominal fat for 60 weeks
  • HTB RSS

Early access

  • MPX vaccine update – access, doses, safer MPX sex 11 August 2022
  • All early access reports

Current issues

  • August 2022
  • July 2022
  • June 2022
  • Back issues

Special report

  • MPX vaccine update – access, doses, safer MPX sex 11 August 2022

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

This site complies with the HONcode standard for trustworthy health information.

Verify here.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Advocate
Professional
Donate
Feedback
Advice and information
Q and A
Phoneline
Pocket info
Guides
HIV meds
Glossary
Research and conference reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
News and updates
News
Blogs
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
Sitemap
Home
Find us on Facebook
i-Base on Facebook